Search Orphan Drug Designations and Approvals
-
Generic Name: | cyclosporine 2% ophthalmic ointment |
---|---|
Date Designated: | 08/01/1991 |
Orphan Designation: | For use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including Mooren's ulcer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Allergan, Inc. 2525 Dupont Drive P. O. Box 19534 Irvine, California 92612 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-